Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Annals of the Rheumatic Diseases|January 7, 2006
Safety of extended treatment with anakinra in patients with rheumatoid arthritisR M Fleischmann, J Tesser, M H Schiff, et al.Archives of Internal Medicine|November 22, 1993
A controlled study comparing the effects of nabumetone, ibuprofen, and ibuprofen plus misoprostol on the upper gastrointestinal tract mucosaS H Roth, E A Tindall, A K Jain, et al.The New England Journal of Medicine|January 28, 1999
A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexateM E Weinblatt, J M Kremer, A D Bankhurst, et al.Transfusion|February 1, 1991
Selective in vivo removal of rheumatoid factor by an extracorporeal treatment device in rheumatoid arthritis patientsH M Lazarus, S B Cohen, D O Clegg, et al.The American Journal of Medicine|October 30, 1987
Controlled evaluation of nabumetone in the treatment of active adult rheumatoid arthritis. Nabumetone versus naproxen double-blind parallel studyF B Vasey, B F Germain, L R Espinoza, et al.The American Journal of Medicine|October 30, 1987
Six-month multi-center study comparing nabumetone with naproxen in the treatment of osteoarthritisE J Pisko, B I Bockow, P Box, et al.Annals of the Rheumatic Diseases|October 31, 2007
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitisJ C Davis, D M van der Heijde, J Braun, et al.The New England Journal of Medicine|July 17, 1997
Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion proteinL W Moreland, S W Baumgartner, M H Schiff, et al.The New England Journal of Medicine|November 30, 2000
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritisJ M Bathon, R W Martin, R M Fleischmann, et al.The Journal of Rheumatology|August 24, 2000
Treatment of rheumatoid arthritis with a DR4/1 peptideE W St Clair, S B Cohen, M L Lee, et al.Pageof 3